Is an estrone-3-glucuronide (E1G) level of 100 on cycle day 20, 7 days past the luteinizing hormone (LH) surge, considered high in a female of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

E1G Level of 100 on Cycle Day 20 (7 Days Post-LH Surge)

An estrone-3-glucuronide (E1G) level of 100 on cycle day 20, which is 7 days after the LH surge, is elevated and represents abnormally high estrogen activity during the mid-luteal phase.

Understanding Normal E1G Patterns

The mid-luteal phase (approximately 7 days post-ovulation) should show a secondary rise in E1G, but this rise is typically modest compared to the preovulatory peak 1, 2. In normal ovulatory cycles:

  • E1G peaks just before the LH surge during the late follicular phase 2, 3
  • After ovulation, E1G levels decline initially, then show a secondary modest elevation during the mid-luteal phase 1, 2
  • The luteal phase E1G elevation is substantially lower than the preovulatory peak 2

Clinical Significance of Elevated E1G at This Timepoint

Your E1G level of 100 at 7 days post-LH surge is concerning for several reasons:

  • Research demonstrates that raised urinary estrone-3-glucuronide excretion in the early luteal phase is associated with reproductive dysfunction, particularly in women with recurrent pregnancy loss 1
  • Elevated E1G during the luteal phase may indicate inappropriate ovarian steroid hypersecretion, which can adversely affect endometrial receptivity 1
  • This pattern is frequently seen alongside LH hypersecretion and elevated testosterone levels, suggesting possible polycystic ovary syndrome (PCOS) or related ovarian dysfunction 1

What This Means for Ovulation Confirmation

Despite the elevated E1G, ovulation confirmation should focus on progesterone metabolites, not estrogen metabolites 4, 5:

  • Pregnanediol-3-glucuronide (PDG) is the gold standard for confirming ovulation occurred 5
  • PDG should show a significant sustained rise during the mid-luteal phase (7 days post-ovulation) 5, 6
  • Serum progesterone ≥5 ng/mL (or urinary PDG equivalent) confirms ovulation 4, 5

Recommended Next Steps

You should obtain concurrent PDG measurement to assess luteal function 5, 6:

  • PDG levels at 7 days post-LH surge will confirm whether adequate progesterone production is occurring 5
  • If PDG is appropriately elevated (confirming ovulation), the high E1G suggests luteal phase hormonal imbalance rather than anovulation 1
  • Consider evaluation for polycystic ovaries and LH hypersecretion, as 81% of women with this pattern of elevated luteal estrogen have polycystic ovaries 1

Clinical Context and Pitfalls

The timing of your measurement (7 days post-LH surge) is optimal for luteal phase assessment 4, 5:

  • This represents the true mid-luteal phase regardless of total cycle length 5
  • However, E1G alone cannot confirm or exclude ovulation—only progesterone metabolites can 4, 5
  • Normal menstrual cycles show significant individual variation in hormone patterns, with 77% differing from "textbook" mean curves 2

If you are trying to conceive or have experienced pregnancy loss, the elevated E1G warrants further investigation for underlying ovarian dysfunction, as this pattern is associated with adverse reproductive outcomes 1.

References

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Day 21 Progesterone Level as an Indicator of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Distinct urinary progesterone metabolite profiles during the luteal phase.

Hormone molecular biology and clinical investigation, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.